Nath Bio-Genes (India) Ltd - 537291 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018.22-10-2022
22-10-2022
Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation on financial results as on 30.09.2022.20-10-2022
Nath Bio-Genes (India) Ltd - 537291 - Board Meeting Outcome for Unaudited Financial Results As On 30.09.2022
Unaudited Financial Results as on 30.09.202220-10-2022
Nath Bio-Genes (India) Ltd - 537291 - Financial Results As On 30.09.2022
Financial Results as on 30.09.202220-10-2022
Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Conference call17-10-2022
Nath Bio-Genes (India) Ltd - 537291 - Board Meeting Intimation for Approval Of Unaudited Financial Results For 30Th Sept 2022.
Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/10/2022 ,inter alia, to consider and approve unaudited financial results for 30th Sept 2022.13-10-2022
Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Resignation of Director
Resignation of Independent Director11-10-2022
Nath Bio-Genes (India) Ltd - 537291 - Closure of Trading Window
Closure of Trading Window30-09-2022
Nath Bio-Genes (India) Ltd - 537291 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Authum Investment & Infrastructure Ltd08-09-2022
Nath Bio-Genes (India) Ltd - 537291 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 01, 2022 for Emerald Seeds Pvt Ltd03-09-2022